bey1107
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 9, 2018 (NCT03579836)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Cyclin-dependent kinase 1INHIBITOR
CDK1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05769660 | Phase 1 | Nov 29, 2022 | BeyondBio Inc. |
| NCT05093907 | Phase 1/Phase 2 (Phase 2) | Aug 31, 2021 | BeyondBio Inc. |
| NCT03579836 | Phase 1/Phase 2 (Phase 2) | May 9, 2018 | BeyondBio Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BeyondBio Inc. | For profit | 3 | 3 | 2 | 2018 |
1 organizations
Page 1 / 1